David Happel

Companies

• Sagimet Biosciences Inc.Board member Jul 13, 2023 to now¹
• Sagimet Biosciences Inc.Chief executive officer Jul 13, 2023 to now¹
• Sagimet Biosciences Inc.President Jul 13, 2023 to now¹
• Horizon Therapeutics Public Ltd CoEVP Global Orphan Bus. Unit Nov 7, 2016 to Oct 26, 2017²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• SBSagimet Biosciences Inc. SGMT741,570 shares³$6.5M at $8.82Jul 20, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 20, 2026Sold 64,051 shares at $7.76 of Sagimet Biosciences Inc.³
• Feb 19, 2026Granted 128,000 shares of Sagimet Biosciences Inc.⁴
• Feb 10, 2026Sold 12,101 shares at $5.36 of Sagimet Biosciences Inc.⁵
• Jul 21, 2025Sold 65,478 shares at $9.13 of Sagimet Biosciences Inc.⁶
• Feb 6, 2025Granted 116,000 shares of Sagimet Biosciences Inc.⁷
• Mar 26, 2024Bought 12,100 shares at $5.27 of Sagimet Biosciences Inc.⁸
• Dec 7, 2023Bought 1,600 shares at $4.10 of Sagimet Biosciences Inc.⁹
• Nov 17, 2023Granted 624,910 shares of Sagimet Biosciences Inc.¹⁰
• Nov 16, 2023Bought 590 shares at $2.35 of Sagimet Biosciences Inc.¹¹